Doximity, Inc. (DOCS) earnings date, results and what the price requires
NYSE · SEC CIK 0001516513 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $156.6M | $24.3M | $0.13 | Filing |
| Mar 31, 2026 | May 13, 2026 | $145.4M | $19.2M | $0.09 | Filing |
| Dec 31, 2025 | Feb 5, 2026 | $185.1M | $61.6M | $0.31 | Filing |
| Sep 30, 2025 | Nov 6, 2025 | $168.5M | $62.1M | $0.31 | Filing |
| Jun 30, 2025 | Aug 7, 2025 | $145.9M | $53.3M | $0.27 | Filing |
| Mar 31, 2025 | May 15, 2025 | $138.3M | $62.5M | $0.31 | Filing |
| Dec 31, 2024 | Feb 6, 2025 | $168.6M | $75.2M | $0.37 | Filing |
| Sep 30, 2024 | Nov 7, 2024 | $136.8M | $44.2M | $0.22 | Filing |
What would Doximity, Inc. have to report for its valuation to change?
At $31.50, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 26.2% a year, to $2.69. On that path the next quarter needs diluted EPS near $0.39, against $0.31 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 26.2% | 26.2% |
| EPS needed in final year | $2.69 | $2.69 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. DOCS goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.